COMMUNIQUÉS West-GlobeNewswire

Radius Health Provides Updates on its Oncology Programs and Announces Scientific Presentations at 2018 San Antonio Breast Cancer Symposium (SABCS)
30/11/2018
Phase 3 elacestrant study has opened for enrollment Fast Track designation from the FDA for the Phase 3 study population Elacestrant pre-clinical data demonstrates further evidence of anti-tumor activity in breast [...]
Glass Lewis Recommends that Keryx Biopharmaceuticals Stockholders Vote “FOR” the Proposed Merger with Akebia Therapeutics
30/11/2018
BOSTON, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced that leading [...]
Agility Health Reports Third Quarter 2018 Financial Results
30/11/2018
HAMILTON, Ontario, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Agility Health, Inc. (TSXV: AHI) (“ Agility Health ” or “ Corporation ”), a leading provider of orthotics, prosthetics and foot care services, today reported its [...]
Holding(s) in Company
30/11/2018
TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the [...]
Vilacto Bio Secured Patent Applications for LACTOACTIVE®
30/11/2018
NEW YORK, Nov. 30, 2018 (GLOBE NEWSWIRE) -- New York-based Vilacto Bio Inc. (OTC QB:VIBI) has secured the patent applications for LACTOACTIVE® covering rights in the US, Canada Europe and Hong Kong. The transaction was [...]
Assure Holdings Announces Results of Annual General Meeting of Shareholders
30/11/2018
DENVER, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV: IOM; OTCPK: ARHH), a provider of intraoperative neuromonitoring services, is pleased to announce that it held its [...]
Wildflower Posts 9th Consecutive Quarter With Increased Revenue
30/11/2018
VANCOUVER, British Columbia, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Wildflower Brands Inc. (CSE: SUN , OTC: WLDFF ) (the “ Company ”) announces more than $1M in sales in its first quarter, compared to $103,893 in the first [...]
SELLAS to Present Further Correlative Data from Phase 2b Trial of NeuVax + Herceptin® at the 2018 San Antonio Breast Cancer Symposium
30/11/2018
NEW YORK, Nov. 30, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel cancer [...]
Oncology Venture A/S: Publication of financial report Q3 2018
30/11/2018
Press release Oncology Venture A/S: Publication of financial report for January – September 2018 Hørsholm, Denmark and Cambridge, MA, US, November 30 th , 2018 – Oncology Venture A/S (“Oncology Venture”) hereby [...]
Cocrystal Pharma Announces Presentation at the RespiDART 2018: Frontiers in Drug Development Against Respiratory Viruses Conference
30/11/2018
- Proprietary technology has the ability to fuel Cocrystal’s pipeline by effectively creating small molecule antiviral therapeutics that are safe, effective, convenient to administer and have the potential to address [...]
IntelGenx Engages Focus Communications for Investor Relations Program
30/11/2018
SAINT LAURENT, Quebec, Nov. 30, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) is pleased to announce the engagement of Focus Communications (“Focus”) to provide [...]
Calithera Biosciences to Participate in the 2018 Citi Global Healthcare Conference
30/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 30, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs directed [...]
Inspire Medical Systems, Inc. Announces Publication of Data From ADHERE Registry
30/11/2018
Data Demonstrated Substantial Reduction in Severity of Obstructive Sleep Apnea with Inspire Therapy Treatment Results from 508 Inspire Therapy Patients Represent Largest International Data Set Generated to Date Data [...]
Brain Scientific To Introduce Two FDA Cleared Devices At American Epilepsy Society Annual Meeting
30/11/2018
NEW YORK, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Brain Scientific Inc. (OTC:BRSF) (“Brain Scientific” or “Company”), a medical device company combining brain analysis software with wireless sensor technologies for [...]
Biohit Oyj’s Financial Reporting and Annual General Meeting in 2019
30/11/2018
Biohit Oyj Financial calendar, November 30, 2018 at 02:45 pm local time (EET) Biohit Oyj will release its financial statements for 2018 on Wednesday 20 th of February 2019 at 9:30 am. The Annual Report, which contains [...]
TG Therapeutics, Inc. Recaps Triple Therapy Data Presentations at the Upcoming 60th American Society of Hematology Annual Meeting and Exposition
30/11/2018
Investor and Analyst Event to be Held on Sunday December 2, 2018 at 7:30 PM PT at the Marriott Gaslamp San Diego with Presentations by Leading Clinical Investigators NEW YORK, Nov. 30, 2018 (GLOBE NEWSWIRE) -- TG [...]
Lenzilumab Study Published in ‘blood’, the Official Journal of the American Society of Hematology (ASH), First Edition
30/11/2018
Lenzilumab (an anti-GM-CSF antibody) in combination with CAR-T cell therapy prevents cytokine release syndrome and neuro-inflammation while improving durable control of leukemic disease Exponential increase in T cell [...]
Editas Medicine Announces FDA Acceptance of IND Application for EDIT-101
30/11/2018
EDIT-101 set to be the first in vivo CRISPR medicine administered to people anywhere in the world Earns $25 million milestone for IND acceptance from partner Allergan CAMBRIDGE, Mass., Nov. 30, 2018 (GLOBE NEWSWIRE) -- [...]
Neos Therapeutics Announces Realignment of Commercial Organization
30/11/2018
– Strategic assessment leads to new salesforce structure and is expected to accelerate path to profitability – – Company to host conference call today at 8:30am ET – DALLAS and FORT WORTH, Texas, Nov. 30, 2018 (GLOBE [...]

Pages